Such effort will encompass using Doppler and strain rate imaging, cardiac MRI, and biomarkers (e.g. troponin, BNP) in a large population to identify precursors of cardiac malfunction in breast cancer treated patients and determine who should be treated at an early stage. Here, NPPB is linked to breast carcinoma.